Tidemark’s Elevance Health ELV Stock Holding History

Tidemark’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$389	Buy	+1	New	+$399	﹤0.01%	959

Other funds holding ELV

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Tidemark's ELV Position: Q3 2026 in Review

Tidemark opened a new position in Elevance Health (ELV) in Q3 2026: 1 share worth $389. The stake represents ﹤0.01% of the portfolio and ranks #959 among its holdings.

1,199 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Tidemark held 1 share of Elevance Health worth $389 as of Q3 2026.
Elevance Health was a new Tidemark position in Q3 2026.
Elevance Health made up ﹤0.01% of Tidemark's portfolio in Q3 2026, its #959 holding.
1,199 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Tidemark's 13F filing for Q3 2026, filed 9 Nov 2026.